CD40 and laryngeal neoplasm: Based on this information, our aimed to assess the potential impacts of CD40 (rs1883832) and CD40L (rs1126535) gene polymorphisms on the susceptibility to larynx cancer as well as serum levels of sCD40 and sCD40L proteins to determine their association with larynx cancer.